Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices – Market Insights – Japan

The Japan EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Japan, improved access to treatment, advancements in cardiac ablation and diagnostic technologies, favorable clinical guidelines supporting cardiac ablation, and clinical evidence supporting the uptake of premium-priced devices.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in Japan from 2019 through 2033.

The entry of PFA devices in Japan has accelerated the race among competitors to establish a foothold in this rapidly growing market.

What will be the growth trajectory of the PFA market in Japan?

What are the latest clinical trial results evaluating PFA devices, and how are they expected to influence market dynamics?

What unique advantages does PFA offer over other ablation techniques, and how will this shape adoption trends?

AF procedure volumes are the high in Japan and continue to be a major focus among electrophysiologists.

How will results from clinical trials impact the current EP market in Japan?

How does AF treatment volume growth compare to other arrhythmia types?

How are manufacturers incorporating novel technologies specifically for AF treatment into their competitive strategies?

A number of advanced technologies are present in the Japanese market.

Which advanced technologies are available in the Japanese EP mapping and ablation device market?

Which of these novel devices have seen the fastest adoption, and why? How will their uptake change over the forecast period?

Which devices are losing ground to these newer, more technologically advanced tools?

The EP diagnostic and ablation catheter segments account for significant market revenues.

What are the changing catheter preferences among electrophysiologists?

What are the growth trends being seen across the different segments?

How will the Japanese MHLW’s biennial reimbursement cuts impact devices across segments?

Table of contents


Related Medtech Insights Reports

Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow strongly through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing…